Pluristem Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PSTI and buy or sell other stocks, ETFs, and their options commission-free!About PSTI
Pluri, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions.
CEOYaky Yanay, CPA
CEOYaky Yanay, CPA
Employees127
Employees127
HeadquartersHaifa, Haifa
HeadquartersHaifa, Haifa
Founded2001
Founded2001
Employees127
Employees127
PSTI Key Statistics
Market cap31.43M
Market cap31.43M
Price-Earnings ratio-0.95
Price-Earnings ratio-0.95
Dividend yield—
Dividend yield—
Average volume17.56K
Average volume17.56K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$7.13
52 Week high$7.13
52 Week low$2.82
52 Week low$2.82
Stock Snapshot
As of today, Pluristem Therapeutics(PSTI) shares are valued at $3.85. The company's market cap stands at 31.43M, with a P/E ratio of -0.95.
Pluristem Therapeutics(PSTI) stock opened on 2026-01-07 at —. The price climbed to — and dipped to —.
The Pluristem Therapeutics(PSTI)'s current trading volume is 0, compared to an average daily volume of 17.56K.
In the last year, Pluristem Therapeutics(PSTI) shares hit a 52-week high of $7.13 and a 52-week low of $2.82.
In the last year, Pluristem Therapeutics(PSTI) shares hit a 52-week high of $7.13 and a 52-week low of $2.82.